Objectives: To quantify the nature and frequency of interventions made by pharmacists during a Medicare annual wellness visit (AWV), to determine the association between the number of medications taken and the interventions made, and to assess patient and physician satisfaction with pharmacist-led AWVs.
T he Patient Protection and Affordable Care Act created several provisions focused on preventive care, including the Medicare annual wellness visit (AWV). 1 AWVs are designed to ensure that preventive screenings are up-to-date, to assess health risks, and to update medical history, including medication use. 2 Primary care physicians have struggled to fulfill all required elements of AWVs while addressing the acute needs of their patients during their allotted visit times. 3 Research has begun to explore the feasibility of alternative care models in which the AWV is led by nonphysician health professionals, including pharmacists. [4] [5] [6] [7] Preliminary work has described the pharmacistled AWV and demonstrated the financial implications of the AWV for pharmacists in primary care settings. [5] [6] [7] Park et al. showed that AWVs provide a way for pharmacists to support their salary in a physician's office. One study briefly detailed the interventions made by a pharmacist during an AWV. 5 Perceived barriers to the pharmacist-led AWV include lack of patient acceptance and physician support; however, there is no current information published assessing patient or physician satisfaction with the pharmacist-led AWV.
Objective
To build on these previous findings, the current article seeks to (1) quantify the nature and frequency of interventions made by a pharmacist providing AWVs; (2) determine the relationship between the number of medications taken and the interventions made during a pharmacist-led AWV; and (3) assess patient and physician satisfaction with pharmacist-led AWV.
Setting
The Mountain Area Health Education Center (MA-HEC) in Asheville, NC, houses a large family medicine residency with an emphasis on multidisciplinary care. A team of physicians, clinical pharmacists, behavioral medicine providers, interpreters, and nurses care for more than 15,000 patients. MAHEC was recognized as a Level 3 Patient-Centered Medical Home in 2011.
Practice description
At MAHEC, five fully integrated pharmacists provide collaborative drug therapy management to patients via North Carolina's clinical pharmacist practitioner (CPP) licensure. The CPP license allows pharmacists to independently initiate, adjust, and discontinue medications as well as order and interpret medication-related tests. 8 Pharmacists meet face-to-face with patients in pharmacotherapy clinics for comprehensive medication management and patient education.
Practice innovation
The implementation of pharmacist-led AWVs at MA-HEC was described previously. 7 Briefly, one pharmacist piloted the AWV clinic in April 2012 for three faculty physicians. The success of this pilot led to the expansion of services to include all patients in November 2012.
As outlined by Medicare, patients are eligible for an AWV if they have had Part B coverage for 1 year and if they have not had a Welcome to Medicare Visit or a previous AWV within the past 12 months. A list of required components of the AWV can be found at the Centers for Medicare and Medicaid Services website.
9 Table 1 summarizes the standing orders developed based on the U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices recommendations. 10, 11 Updating the patient's medication list is one of the required components of the AWV; however, in the pharmacist-led AWV at MAHEC, services were expanded to include comprehensive medication management as described by the Patient-Centered Primary Care Collaborative. 12 The pharmacist used interventions permitted under the CPP license to resolve any medication-related problems identified during the AWV.
Evaluation
We completed a retrospective chart review of all patients who completed a pharmacist-led AWV between April 1, 2012, and January 31, 2013, to determine the nature and frequency of interventions made by the pharmacist. Two separate surveys were then administered to assess patient and physician satisfaction with the pharmacistled AWV.
Key Points

Background:
❚ The pharmacist-led Medicare annual wellness visit (AWV) has been proposed as a way to further integrate clinical pharmacy services into primary care settings given the revenuegenerating potential of these visits. ❚ Little is known about the impact pharmacists can have on medication management during these visits and how receptive patients and physicians may be to the pharmacist-led AWV.
Findings:
❚ During the AWV in a family medicine practice, pharmacists made 3.6 medication interventions per patient. The number of medications per patient was positively associated with the total number of medication interventions made. ❚ Physicians and patients reported satisfaction with the pharmacist-led AWV.
Mission Hospitals' Institutional Review Board approved this project.
Nature and frequency of interventions
Interventions were divided into two main categories: medication and nonmedication interventions. We defined our medication interventions using the PatientCentered Primary Care Collaborative framework for identifying medication-related problems, by assessing a medication for appropriateness, effectiveness, safety, and adherence. 12 Specific medication interventions were defined as new therapy recommended, dose/frequency/duration adjustment, interaction identified, duplicate/unnecessary medication discontinued, adverse effect addressed, and electronic health record medication list discrepancy resolved. A discrepancy in the patient's electronic health record medication list could include the following: a patient appropriately taking an unlisted medication, patient inappropriately taking an unlisted medication, and patient inappropriately or not taking a listed medication. We classified nonmedication interventions as one of the following: vaccination required, preventive screening referral placed, laboratory tests ordered, impairment identified, primary care provider (PCP) appointment made, and other.
Vaccines were considered nonmedication interventions because pharmacists do not administer vaccines at this site. The clinic's workflow is designed for the medical assistants to administer vaccines ordered by the providers.
Interventions classified as 'other' included referral to a MAHEC clinic such as pharmacotherapy, falls, or osteoporosis clinic to further address a problem identified during the AWV; smoking cessation counseling provided; diet or exercise counseling provided; and additional routine screenings completed (i.e., thyroid stimulating hormone). Interventions were marked as complete if appropriate documentation was found in the note from the visit.
Patient satisfaction
A patient satisfaction survey was distributed to patients seen for pharmacist-led AWVs between April 1, 2012, and October 31, 2012, as an internal quality assurance measure. Patients were asked to use a 1-5 Likert scale to indicate their level of agreement or satisfaction with specific statements regarding their pharmacist-led visit. At the conclusion of the visit, the pharmacist gave the survey to the patient to complete and return to check out upon leaving.
Physician satisfaction
A physician satisfaction survey was developed to assess physician perceptions of the pharmacist-led AWV. The physician survey consisted of five statements assessed on a 1-5 Likert scale. The surveys were distributed and collected by the pharmacist at a faculty meeting on July 24, 2013.
Analyses
Two correlations were computed to ascertain the strength of the relationship between the number of med- 
Results
Data were collected on 69 patients. Baseline demographics are summarized in Table 2 . Patients were taking a mean of 12.2 medications (SD = 5.1). The pharmacist made 589 interventions, the majority of which were related to medications. This resulted in an average of 3.6 medication interventions per patient. The most common medication intervention was identifying and correcting a discrepancy in the medication list. A summary of medication-related interventions is found in Table 3 . Nonmedication interventions are summarized in Table 4 . The pharmacist addressed 342 nonmedication interventions, averaging 4.9 per patient. The most common nonmedication intervention was vaccine-related interventions with each patient requiring a mean of 1.4 vaccines (SD = 1.2). Of these, 17% were referred back to the PCP for complete advanced care planning. Other reasons patients were referred back to the PCP included addressing chronic diseases and determining the need for preventive screening in situations where the patient fell outside of or did not agree with U.S. Preventive Services Task Force recommendations.
The number of medications taken was positively associated with the number of medication interventions made (r = 0.37, P <0.01). The number of medications taken was not associated with the total number of interventions (medication and nonmedication) made (r = −0.13, P = 0.14).
Patient and physician satisfaction survey responses are summarized in Table 5 . Of the 51 patients seen during the time period in which satisfaction surveys were distributed, 32 surveys were collected (response rate 62.7%). Patients strongly agreed that the AWV was important for their overall health (mean 4.8, median 5) and disagreed that they were expecting a physical examination (mean 2.1, median 1). Patients were neutral about their preference of seeing their PCP for the AWV (mean 2.8, median 3). Patients strongly agreed that they will repeat the AWV next year (mean 4.9, median 5) and that they would like to see the same provider (mean 4.8, median 5).
Of the 17 faculty physicians, 10 were present for survey administration and all 10 surveys were collected (response rate 100%). Physicians agreed that patients are willing to see the pharmacist for their AWVs (mean 4.2, median 4) and strongly agreed that patients have benefited from the AWVs with the pharmacist (mean 4.9, median 5). Physicians strongly disagreed that they would prefer to conduct the AWVs themselves (mean 1.5, median 1).
Discussion
To date, three articles have described pharmacist-led AWVs. [5] [6] [7] This article builds on those by further detailing interventions made during the visit, determining if there is a relationship between the number of medications and interventions made, and presenting patient and physician satisfaction surveys.
Pharmacists were able to address both medication and nonmedication interventions. Standing orders and a collaborative practice agreement allowed pharmacists to take direct action during the visit. This system allows for a more efficient and coordinated approach to care. Further studies are needed to assess whether interventions that require subsequent action by the patient (i.e., colonoscopy) are actually completed and, ultimately, if clinical outcomes are improved.
The positive association between the number of medications taken and medication interventions suggests that comprehensive medication management by a pharmacist during the AWV is particularly useful in patients with a higher medication burden. In areas where pharmacists are limited, a useful strategy may be to have pharmacists conduct the AWV for patients with more extensive medication lists. The lack of association between medications taken and the total number of interventions demonstrates the benefit that the pharmacist may have on nonmedication interventions for all patients, regardless of the number of medications taken. This may reflect the effective use of standing orders to address the preventive care needs of the patient.
Before implementation, we believed that barriers to the pharmacist-led AWV would include patient unwill- Table 2 . Baseline patient demographics (n = 69)
Characteristics Result
Age, years (mean ± SD) 74.0 ± 8. ingness to see the pharmacist, patient misconceptions of what the AWV entails, and physician reluctance to embrace the pharmacist-led AWV. The survey results suggested that many of these perceived barriers did not exist. Both patients and physicians were satisfied with pharmacist-led AWVs. Patients did not express concern over not seeing their physician during the visit. This was likely due to MAHEC's efforts to set clear expectations regarding visit components when scheduling patients.
Results of the physician survey were also positive. We saw that physicians embraced the pharmacist-led AWV and believed their patients benefited from them. As team-based care evolves, the support of the physician is imperative to effectively implement clinical pharmacy services. As the team leader, a physician champion can advocate for pharmacists to other stakeholders including patients, practice managers, and billing and/or compliance officers in order to gain the support required for successful integration. These results suggest that at this practice physicians welcomed pharmacist-led AWVs.
This project demonstrates the positive impact of the pharmacist-led AWV in one academic, family medicine practice. As team-based, quality-driven care evolves, there will be increasing demand for pharmacy services in the ambulatory care setting. However, until provider status is achieved, the inability to adequately bill for services will continue to be a main barrier for fully integrating the clinical pharmacist. These positive results, combined with the revenue generating potential of the AWV, provide a compelling argument for using the pharmacist-led AWV as a vehicle to implement and augment clinical pharmacy services in the primary care setting. It is important to replicate this service at multiple different practice sites, including private practice, hospital-based clinics, and internal medicine practices, to assess the generalizability of this success to other settings.
Limitations
Assessing the nature and frequency of interventions by chart review was limited by how well the pharmacist documented the visit at the time of the encounter. 
EXPERIENCE MEDICATION DISPENSING AFTER ELECTRONIC DISCONTINUATION
Some of the interventions required referrals to outside providers, but we did not assess whether patients acted on these interventions. To date, no data is available assessing the long-term impact of the AWV on patient outcomes. North Carolina's CPP license is very broad; pharmacists in other states may not have the same scope of practice to implement medication-related interventions. However, the majority of states have some type of collaborative practice agreements. In addition, all nonmedication interventions can be completed by the pharmacist through creating standing orders within the practice.
Satisfaction surveys were used for internal quality assurance purposes and thus were not validated before use. Selection bias may exist for the physician survey since it was administered only to those in attendance at one faculty meeting. Further, this innovation occurred within an academic practice where patients and physicians are accustomed to working with pharmacists and thus may already have a more favorable opinion of their role on the team.
Conclusion
Pharmacists conducting AWVs were able to address both medication and nonmedication interventions for patients during an AWV. Patients and physicians were satisfied with the pharmacist-led AWV at one family medicine practice. This study showed that the pharmacist-led AWV provides the opportunity to expand pharmacist-provided direct patient care services in the primary care setting.
